Arthritis Rheum. 1994 Nov;37(11):1593-601.

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.

Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, MacKillip F.

Source

Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7874.

Abstract

OBJECTIVE:

To measure, and seek clinical correlates with, levels of substance P (SP) in the cerebrospinal fluid (CSF) of fibromyalgia syndrome (FMS) patients.

METHODS:

CSF from 32 FMS patients and 30 normal control subjects was tested for SP by radioimmunoassay. Clinical measures included tender point examination and standardized questionnaires.

RESULTS:

CSF SP levels were 3-fold higher in FMS patients than in normal controls (P < 0.001), but they correlated only weakly with tenderness found on examination.

CONCLUSION:

SP is significantly elevated in FMS CSF, but other abnormalities must exist in FMS to more fully explain the symptoms.

PMID:: 7526868; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Substance P

LinkOut - more resources

Medical

Fibromyalgia - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). [J Rheumatol. 1988]
Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome).
Vaeroy H, Helle R, Førre O, Kåss E, Terenius L. J Rheumatol. 1988 Dec; 15(12):1804-6.
Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. [Pain. 1998]
Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome.
Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S, Terenius L, Henriksson KG. Pain. 1998 Nov; 78(2):153-5.
Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. [Pain. 2000]
Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways.
Larson AA, Giovengo SL, Russell IJ, Michalek JE. Pain. 2000 Aug; 87(2):201-11.
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. [Pain. 1988]
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.
Vaerøy H, Helle R, Førre O, Kåss E, Terenius L. Pain. 1988 Jan; 32(1):21-6.
Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP). [J Rheumatol Suppl. 1989]
Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP).
Vaerøy H, Sakurada T, Førre O, Kåss E, Terenius L. J Rheumatol Suppl. 1989 Nov; 19:94-7.

See reviews... See all...

Cited by 27 PubMed Central articles

Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. [Pain Res Treat. 2012]
Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.
Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Pain Res Treat. 2012; 2012:426130. Epub 2012 Nov 4.
Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides. [Arthritis Res Ther. 2012]
Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides.
Bjersing JL, Dehlin M, Erlandsson M, Bokarewa MI, Mannerkorpi K. Arthritis Res Ther. 2012 Jul 9; 14(4):R162. Epub 2012 Jul 9.
Fibromyalgia and depression. [Pain Res Treat. 2012]
Fibromyalgia and depression.
Gracely RH, Ceko M, Bushnell MC. Pain Res Treat. 2012; 2012:486590. Epub 2011 Nov 19.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Elevated cerebrospinal fluid levels of substance P in patients with the fibromya...
Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.
Arthritis Rheum. 1994 Nov ;37(11):1593-601.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: